Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioventus Inc Cl A (BVS)

Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 608,308
  • Shares Outstanding, K 82,763
  • Annual Sales, $ 573,280 K
  • Annual Income, $ -33,540 K
  • EBIT $ 85 M
  • EBITDA $ 135 M
  • 60-Month Beta 0.80
  • Price/Sales 1.09
  • Price/Cash Flow 7.07
  • Price/Book 3.02

Options Overview Details

View History
  • Implied Volatility 178.96% ( -39.33%)
  • Historical Volatility 54.11%
  • IV Percentile 98%
  • IV Rank 66.77%
  • IV High 252.49% on 10/29/25
  • IV Low 31.23% on 09/04/25
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 71
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 1,452
  • Open Int (30-Day) 1,194

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.15
  • Growth Rate Est. (year over year) +665,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.50 +13.08%
on 11/03/25
8.26 -11.02%
on 11/04/25
+0.67 (+10.03%)
since 10/14/25
3-Month
6.26 +17.51%
on 09/26/25
8.26 -11.02%
on 11/04/25
+0.01 (+0.14%)
since 08/14/25
52-Week
5.81 +26.51%
on 08/05/25
12.61 -41.71%
on 11/27/24
-3.78 (-33.96%)
since 11/14/24

Most Recent Stories

More News
Bioventus: Q3 Earnings Snapshot

Bioventus: Q3 Earnings Snapshot

BVS : 7.35 (-2.91%)
Bioventus Reports Third Quarter Financial Results

Q3 reported revenue of $138.7 million was comparable to last year and organic* revenue advanced 8% Third quarter GAAP earnings of $0.05 per diluted share increased compared to the prior-year...

BVS : 7.35 (-2.91%)
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025

DURHAM, N.C., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will...

BVS : 7.35 (-2.91%)
Halper Sadeh LLC Encourages Bioventus Inc. Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

BVS : 7.35 (-2.91%)
Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

DURHAM, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, Bioventus Senior Vice-President...

BVS : 7.35 (-2.91%)
Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference

DURHAM, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Bioventus President and Chief Executive...

BVS : 7.35 (-2.91%)
Bioventus: Q2 Earnings Snapshot

Bioventus: Q2 Earnings Snapshot

BVS : 7.35 (-2.91%)
Bioventus Reports Second Quarter Financial Results

Q2 reported revenue of $147.7 million declined 2.4% ; Organic* revenue advanced 6.2% Second quarter diluted earnings per share was $0.11 compared to a diluted loss per share of $0.40...

BVS : 7.35 (-2.91%)
Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity

DURHAM, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has entered...

BVS : 7.35 (-2.91%)
Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products

DURHAM, N.C., July 30, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, announced today a significant milestone with the U.S. Food and Drug Administration...

BVS : 7.35 (-2.91%)

Business Summary

Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.

See More

Key Turning Points

3rd Resistance Point 7.79
2nd Resistance Point 7.65
1st Resistance Point 7.50
Last Price 7.35
1st Support Level 7.22
2nd Support Level 7.08
3rd Support Level 6.93

See More

52-Week High 12.61
Fibonacci 61.8% 10.01
Fibonacci 50% 9.21
Fibonacci 38.2% 8.41
Last Price 7.35
52-Week Low 5.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar